← Scroll for more →
Rapport Therapeutics, Inc. (RAPP)
Pharmaceutical Preparations
Latest Price
$25.05
TTM P/E
--
Normalized P/E
--
TTM Div Yield
--
Fwd Div Yield
--
Book Value
8.84
P/B Ratio
2.83
Institutional Ownership
100.0% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| FMR LLC | 7.17M | $298.0M | 14.96% | +4.0K | 2026-06-30 |
| Trv GP V, LLC | 6.28M | $261.0M | 13.10% | -854.7K | 2026-06-30 |
| ARCH Venture Management, LLC | 3.73M | $155.0M | 7.78% | -- | 2026-06-30 |
| Capital International Investors | 2.92M | $121.0M | 6.09% | -176.0K | 2026-06-30 |
| Goldman Sachs Group Inc | 2.91M | $121.0M | 6.07% | -31.8K | 2026-06-30 |
| BlackRock, Inc. | 2.70M | $112.0M | 5.63% | +193.8K | 2026-06-30 |
| Cormorant Asset Management, LP | 2.66M | $110.0M | 5.54% | -300.0K | 2026-06-30 |
| Sofinnova Investments, Inc. | 1.90M | $79.0M | 3.97% | -- | 2026-06-30 |
| Johnson & Johnson | 1.78M | $74.0M | 3.72% | -- | 2026-06-30 |
| Polar Capital Holdings Plc | 1.61M | $67.0M | 3.35% | -33.9K | 2026-06-30 |